![Philip Johnson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Johnson
President chez
SIGILON THERAPEUTICS, INC.
Fortune : 14 M $ au 30/06/2026
Profil
Philip L.
Johnson is currently Director at The American Chamber of Commerce in Japan, Director at Dermira, Inc. since 2020, President & Director at Sigilon Therapeutics, Inc. since 2023, President at DICE Therapeutics, Inc. since 2023, and Chief Financial Officer & Executive Vice President at both Jazz Pharmaceuticals Plc and Jazz Pharmaceuticals, Inc. since 2024.
Former roles include Chief Executive Officer at ARMO Biosciences, Inc., President & Director at Akouos, Inc., President & Director at POINT Biopharma Global, Inc., President & General Manager at Eli Lilly Italia SpA, and Treasurer & Senior Vice President-Finance at Eli Lilly & Co. Education includes undergraduate studies at the University of Illinois and graduate studies at Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2026 | 56 431 ( 0,09 % ) | 14 M $ | 30/06/2026 |
Postes actifs de Philip Johnson
| Sociétés | Poste | Début |
|---|---|---|
| DERMIRA, INC. | Directeur/Membre du Conseil | 20/02/2020 |
| DICE THER | President | 09/08/2023 |
| SIGILON THERAPEUTICS, INC. | President | 11/08/2023 |
| JAZZ PHARMACEUTICALS PLC | Directeur Financier/CFO | 01/03/2024 |
The American Chamber of Commerce in Japan
 The American Chamber of Commerce in Japan Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Directeur/Membre du Conseil | - |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Directeur Financier/CFO | 01/03/2024 |
Anciens postes connus de Philip Johnson
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Investor Relations Contact | 01/01/2018 |
| POIT BIOP | President | - |
| AKOUOS | President | - |
| ░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
| ░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Philip Johnson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The American Chamber of Commerce in Japan
The American Chamber of Commerce in Japan Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Commercial Services |
Eli Lilly Italia SpA
 Eli Lilly Italia SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
Akouos, Inc.
 Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
POINT Biopharma Global, Inc.
 POINT Biopharma Global, Inc. BiotechnologyHealth Technology Develops radioligand therapies for the treatment of cancer | Health Technology |
